Abiopharma

🔍 Olivera Matias (Executive)

Company: Exodus Movement, Inc. (EXOD)

Report Date: 2026-08-19

Detailed Transactions and Holdings:

• Sold 2,835 shares of Class A Common Stock at $7.0319 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | shares_owned_after: 337,263.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,835 shares of Class A Common Stock at $7.73 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 334,428.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: 1. The price reported is a weighted average sale price of the Class A common stock, par value $0.000001 per share, of the Issuer ("Common Stock"). These shares were sold in multiple transactions at prices ranging from $7.00 to $7.17, inclusive. The Reporting Person undertakes to provide to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F2: Includes (i) 2,171 Restricted Stock Units ("RSU") originally granted on January 1, 2023 that vest in equal monthly installments through January 1, 2027 and (ii) 18,615 RSUs originally granted on July 1, 2023 that vest in equal monthly installments through July 1, 2027 and (iii) 36,214 RSUs originally granted on March 13, 2024 that vest in equal monthly installments through January 1, 2028 and (iv) 25,818 RSUs originally granted on May 21, 2025 that vest in equal monthly installments through January 1, 2029 and (v) 41,667 RSUs originally granted on December 30, 2025 that vest in equal monthly installments through December 1, 2029. Each RSU represents the right to receive one share of Common Stock upon settlement.